Navigation Links
Chelation Therapy Drug Found Safe and Beneficial for Children With Autism
Date:11/5/2009

The Autism Research Institute calls for further investigations into the use of chelation therapy for individuals with autism

SAN DIEGO, Nov. 5 /PRNewswire-USNewswire/ -- Two studies published by the Southwest College of Naturopathic Medicine in the October issue of BMC Clinical Pharmacology investigated the use of oral dimercaptosuccinic acid (DMSA), a prescription medicine approved by the FDA for treating lead poisoning, and used off-label in these studies for treating heavy metal toxicity in children with autism.

In the investigations, DMSA was given to 65 children with autism (ages 3 -8 years) to determine its effects. The researchers found that DMSA dramatically increased excretion of several toxic metals, including a 10-fold increase in excretion of lead. In terms of safety, the study found that there was no adverse effect on standard safety tests, including no effect on kidney or liver function.

Of greatest interest was a surprising finding that DMSA therapy had a dramatic effect on glutathione levels. Glutathione is the body's primary defense against toxic metals, and it was very abnormal in children with autism. Treatment with DMSA for only 3 days normalized glutathione levels for at least 1-2 months in almost all children.

DMSA therapy also had promising effects on possibly reducing some of the symptoms of autism, including improvements in language, cognition, and sociability. However, a formal randomized double-blind placebo-controlled study is needed to confirm those results.

The study was led by Matthew Baral, N.D., Chair of the Department of Pediatric Medicine and Associate Professor of Pediatrics at Southwest College of Naturopathic Medicine (SCNM) and James B. Adams, Ph.D., Adjunct Professor in the Division of Clinical Sciences at SCNM and Science Director for the Autism Research Institute.

"Toxic metals are a common problem in autism, and I have personally observed that many of my patients with autism have greatly benefited from DMSA therapy. I hope this data answers the question that many physicians have: whether chelation is safe and effective, and clearly it's both," says Dr. Matthew Baral. "This study shows that DMSA therapy is safe and effective, and should be considered as a possible treatment for children with autism who have significant body burden of toxic metals," says Prof. James Adams.

This study was funded, in part, by the Autism Research Institute. To access the studies go to

http://www.biomedcentral.com/1472-6904/9/16

http://www.biomedcentral.com/1472-6904/9/17

SOURCE Autism Research Institute


'/>"/>
SOURCE Autism Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Sports Bracing and Therapy Experts Re-Launch Website BetterBraces.com
2. Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
3. Short-Term Hormone Therapy Added to Radiation Increases Survival for Medium-Risk, But Not Low-Risk, Prostate Cancer Patients
4. Stereotactic Radiotherapy Stops Lung Cancer From Growing in Frail Patients
5. Adding Proton Therapy Boost to X-Ray Radiation Therapy Reduces Prostate Cancer Recurrences
6. Task force develops new radiation guidelines for brachytherapy
7. Hormone Therapy Can Help Some With Prostate Cancer
8. New Study Finds Shock-Wave Therapy for Unhealed Fractured Bones as Effective as Surgery
9. SleepApneaUSA.net Announced New 2010 ZHT (Zhou's Hypoxicology Therapy) Certification Class For Sleep Apnea As A No-Surgery And No-Device Alternative
10. Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
11. Immunotherapy Demonstrates Long-Term Success in Treating Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... CURE Media ... centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat ... the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
Breaking Medicine Technology: